Catalyst Wire Dossier Catalyst Wire Dossier

AMPHADASE

Hyaluronidase · Amphastar Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AMPHADASE, covering 2012-06-28 to 2024-08-28. Get the full timeline:

Most recent: FDA Approved: AMPHADASE — Supplemental Application (Amphastar Pharmaceuticals, Inc.)

See pricing